Regorafenib A Multi-Kinase Inhibitor for Refractory Cancers – Mechanism, Clinical Applications, and Emerging Insights

Innovative Research Journals

Regorafenib A Multi-Kinase Inhibitor for Refractory Cancers – Mechanism, Clinical Applications, and Emerging Insights Introduction Regorafenib is an orally administered multikinase inhibitor used in the treatment of various refractory cancers. Approved by the U.S. FDA in 2012, it offers a new line […]

Read More

Cardiotoxicity Mechanisms, Risk Factors, and Clinical Implications in Modern Medicine

Innovative Research Journals

Cardiotoxicity Mechanisms, Risk Factors, and Clinical Implications in Modern Medicine Introduction Cardiotoxicity refers to damage inflicted on the heart muscle (myocardium) by chemical substances, particularly pharmaceutical drugs or environmental toxins. This condition is increasingly significant in clinical practice due to the widespread […]

Read More